AVAVA Receives FDA 510(k) Clearance to Treat Benign Pigment Lesions, Including Hyperpigmentation
AVAVA is a disruptive medical aesthetics technology platform company providing breakthrough treatments for all skin tones
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Aug 22
AVAVA is a disruptive medical aesthetics technology platform company providing breakthrough treatments for all skin tones
05 Aug 22
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve…
29 Jul 22
Once infected, monkeypox causes headaches along with fever, muscle aches, and fatigue, and it is known to irritate…
22 Jul 22
Natus is engaged in designing, manufacturing and distributing medical device solutions for screening, diagnosis, and treatment of the…
19 Jul 22
The Renuvion APR Handpieces are now indicated for use in subcutaneous dermatological and aesthetic procedures to improve the…
11 Jul 22
The Agreement covers the sales & marketing of LASEROPTEK's expanding line of FDA cleared aesthetic laser systems to…
08 Jul 22
Medios AI is not US FDA approved and not available in the US
06 Jul 22
Evidence Solution was established in 2019, its witnessing system has been designed in close cooperation with fertility clinics…
17 Jun 22
Following Completion of EU Declaration of Conformity to European MDR
02 Jun 22
Equipped with patented Skintel technology, the Elite iQ platform offers customised laser hair removal treatments for all skin…